All Sauce from Weekly Sauce:

Adults with peanut allergies can be safely treated using exposure therapy to increase their resistance, new clinical trial results show. More than two-thirds of participants (67%) gained the ability to tolerate at least five peanuts without an immune reaction, researchers report in the journal Allergy. This is the first trial to test exposure therapy in…  read on >  read on >

Breast cancer patients fare better if they continue to exercise during their treatment, and a new program can help women get the activity they need to boost their odds, researchers say. The Comprehensive Oncology Rehabilitation and Exercise (CORE) program assesses women’s physical activity needs based on the stage to which their cancer has progressed, researchers…  read on >  read on >

The more ultra-processed food a person regularly eats, the higher their risk of an early death, a new evidence review has concluded. Each 10% increase in ultra-processed foods in a person’s diet increases their risk of early death from any cause by 3%, researchers reported today in the American Journal of Preventive Medicine. It’s estimated…  read on >  read on >

Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Novavax’s stock up more than 21% in early trading. It also helped ease fears that the decision had been delayed by the Trump Administration, the Associated Press reported. Novavax makes the only…  read on >  read on >

Four specific genes serve as a telltale clue to how potentially deadly stomach cancers will develop and progress, a new study says. Testing for these genetic mutations could enable doctors to offer targeted treatments and spare some patients from going through aggressive measures like surgery or chemotherapy, researchers will argue at the upcoming medical conference…  read on >  read on >

Doctors can accurately predict a person’s risk of fatty liver disease as early as 16 years before symptoms develop, a new study says. A blood test looking for five specific proteins can predict metabolic dysfunction-associated steatotic liver disease (MASLD), more commonly known as fatty liver disease, researchers are scheduled to report at the upcoming Digestive…  read on >  read on >